140 related articles for article (PubMed ID: 23917454)
1. Molecular signatures of epithelial ovarian cancer: analysis of associations with tumor characteristics and epidemiologic risk factors.
Schildkraut JM; Iversen ES; Akushevich L; Whitaker R; Bentley RC; Berchuck A; Marks JR
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1709-21. PubMed ID: 23917454
[TBL] [Abstract][Full Text] [Related]
2. Validation of ovarian cancer gene expression signatures for survival and subtype in formalin fixed paraffin embedded tissues.
Sfakianos GP; Iversen ES; Whitaker R; Akushevich L; Schildkraut JM; Murphy SK; Marks JR; Berchuck A
Gynecol Oncol; 2013 Apr; 129(1):159-64. PubMed ID: 23274563
[TBL] [Abstract][Full Text] [Related]
3. Correlations among ERCC1, XPB, UBE2I, EGF, TAL2 and ILF3 revealed by gene signatures of histological subtypes of patients with epithelial ovarian cancer.
Guo Y; Fu P; Zhu H; Reed E; Remick SC; Petros W; Mueller MD; Yu JJ
Oncol Rep; 2012 Jan; 27(1):286-92. PubMed ID: 21971700
[TBL] [Abstract][Full Text] [Related]
4. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
5. Type II diabetes mellitus and the incidence of epithelial ovarian cancer in the cancer prevention study-II nutrition cohort.
Gapstur SM; Patel AV; Diver WR; Hildebrand JS; Gaudet MM; Jacobs EJ; Campbell PT
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2000-5. PubMed ID: 22941335
[TBL] [Abstract][Full Text] [Related]
6. Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells.
Winterhoff BJ; Maile M; Mitra AK; Sebe A; Bazzaro M; Geller MA; Abrahante JE; Klein M; Hellweg R; Mullany SA; Beckman K; Daniel J; Starr TK
Gynecol Oncol; 2017 Mar; 144(3):598-606. PubMed ID: 28111004
[TBL] [Abstract][Full Text] [Related]
7. POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer.
Karlan BY; Dering J; Walsh C; Orsulic S; Lester J; Anderson LA; Ginther CL; Fejzo M; Slamon D
Gynecol Oncol; 2014 Feb; 132(2):334-42. PubMed ID: 24368280
[TBL] [Abstract][Full Text] [Related]
8. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
9. Characterization of fusion genes in common and rare epithelial ovarian cancer histologic subtypes.
Earp MA; Raghavan R; Li Q; Dai J; Winham SJ; Cunningham JM; Natanzon Y; Kalli KR; Hou X; Weroha SJ; Haluska P; Lawrenson K; Gayther SA; Wang C; Goode EL; Fridley BL
Oncotarget; 2017 Jul; 8(29):46891-46899. PubMed ID: 28423358
[TBL] [Abstract][Full Text] [Related]
10. A distinctive ovarian cancer molecular subgroup characterized by poor prognosis and somatic focal copy number amplifications at chromosome 19.
Sung CO; Song IH; Sohn I
Gynecol Oncol; 2014 Feb; 132(2):343-50. PubMed ID: 24321399
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for epithelial ovarian cancer by histologic subtype.
Gates MA; Rosner BA; Hecht JL; Tworoger SS
Am J Epidemiol; 2010 Jan; 171(1):45-53. PubMed ID: 19910378
[TBL] [Abstract][Full Text] [Related]
12. Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies.
Faber MT; Kjær SK; Dehlendorff C; Chang-Claude J; Andersen KK; Høgdall E; Webb PM; Jordan SJ; ; ; Rossing MA; Doherty JA; Lurie G; Thompson PJ; Carney ME; Goodman MT; Ness RB; Modugno F; Edwards RP; Bunker CH; Goode EL; Fridley BL; Vierkant RA; Larson MC; Schildkraut J; Cramer DW; Terry KL; Vitonis AF; Bandera EV; Olson SH; King M; Chandran U; Kiemeney LA; Massuger LF; van Altena AM; Vermeulen SH; Brinton L; Wentzensen N; Lissowska J; Yang HP; Moysich KB; Odunsi K; Kasza K; Odunsi-Akanji O; Song H; Pharaoh P; Shah M; Whittemore AS; McGuire V; Sieh W; Sutphen R; Menon U; Gayther SA; Ramus SJ; Gentry-Maharaj A; Pearce CL; Wu AH; Pike MC; Risch HA; Jensen A;
Cancer Causes Control; 2013 May; 24(5):989-1004. PubMed ID: 23456270
[TBL] [Abstract][Full Text] [Related]
13. Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and Nutrition.
Ose J; Fortner RT; Rinaldi S; Schock H; Overvad K; Tjonneland A; Hansen L; Dossus L; Fournier A; Baglietto L; Romieu I; Kuhn E; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Masala G; Sieri S; Tumino R; Sacerdote C; Mattiello A; Ramon Quiros J; Obón-Santacana M; Larrañaga N; Chirlaque MD; Sánchez MJ; Barricarte A; Peeters PH; Bueno-de-Mesquita HB; Onland-Moret NC; Brändstedt J; Lundin E; Idahl A; Weiderpass E; Gram IT; Lund E; Kaw KT; Travis RC; Merritt MA; Gunther MJ; Riboli E; Kaaks R
Int J Cancer; 2015 Jan; 136(2):399-410. PubMed ID: 24890047
[TBL] [Abstract][Full Text] [Related]
14. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.
Rechsteiner M; Zimmermann AK; Wild PJ; Caduff R; von Teichman A; Fink D; Moch H; Noske A
Exp Mol Pathol; 2013 Oct; 95(2):235-41. PubMed ID: 23965232
[TBL] [Abstract][Full Text] [Related]
15. An IL6-correlated signature in serous epithelial ovarian cancer associates with growth factor response.
Pinciroli P; Alberti C; Sensi M; Canevari S; Tomassetti A
BMC Genomics; 2013 Jul; 14():508. PubMed ID: 23889749
[TBL] [Abstract][Full Text] [Related]
16. The NER-related gene GTF2H5 predicts survival in high-grade serous ovarian cancer patients.
Gayarre J; Kamieniak MM; Cazorla-Jiménez A; Muñoz-Repeto I; Borrego S; García-Donas J; Hernando S; Robles-Díaz L; García-Bueno JM; Ramón Y Cajal T; Hernández-Agudo E; Heredia Soto V; Márquez-Rodas I; Echarri MJ; Lacambra-Calvet C; Sáez R; Cusidó M; Redondo A; Paz-Ares L; Hardisson D; Mendiola M; Palacios J; Benítez J; García MJ
J Gynecol Oncol; 2016 Jan; 27(1):e7. PubMed ID: 26463438
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and prognostic factors in patients with double primary cancer: epithelial ovarian cancer and breast cancer.
Cvelbar M; Ursic-Vrscaj M; Rakar S
Eur J Gynaecol Oncol; 2005; 26(1):59-63. PubMed ID: 15755003
[TBL] [Abstract][Full Text] [Related]
18. CD73 is associated with poor prognosis in high-grade serous ovarian cancer.
Turcotte M; Spring K; Pommey S; Chouinard G; Cousineau I; George J; Chen GM; Gendoo DM; Haibe-Kains B; Karn T; Rahimi K; Le Page C; Provencher D; Mes-Masson AM; Stagg J
Cancer Res; 2015 Nov; 75(21):4494-503. PubMed ID: 26363007
[TBL] [Abstract][Full Text] [Related]
19. TNF-α expression, risk factors, and inflammatory exposures in ovarian cancer: evidence for an inflammatory pathway of ovarian carcinogenesis?
Gupta M; Babic A; Beck AH; Terry K
Hum Pathol; 2016 Aug; 54():82-91. PubMed ID: 27068525
[TBL] [Abstract][Full Text] [Related]
20. Molecular Signature for Lymphatic Invasion Associated with Survival of Epithelial Ovarian Cancer.
Paik ES; Choi HJ; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
Cancer Res Treat; 2018 Apr; 50(2):461-473. PubMed ID: 28546526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
